CHEK
Price
$0.67
Change
+$0.02 (+3.08%)
Updated
Apr 24, 04:49 PM (EDT)
Capitalization
18.19M
14 days until earnings call
TWST
Price
$40.17
Change
+$2.55 (+6.78%)
Updated
Apr 24 closing price
Capitalization
1.98B
10 days until earnings call
Ad is loading...

CHEK vs TWST

Header iconCHEK vs TWST Comparison
Open Charts CHEK vs TWSTBanner chart's image
Check-Cap
Price$0.67
Change+$0.02 (+3.08%)
Volume$100
Capitalization18.19M
Twist Bioscience
Price$40.17
Change+$2.55 (+6.78%)
Volume$736.4K
Capitalization1.98B
CHEK vs TWST Comparison Chart
Loading...
CHEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CHEK vs. TWST commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHEK is a Hold and TWST is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (CHEK: $0.67 vs. TWST: $40.17)
Brand notoriety: CHEK and TWST are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CHEK: 7% vs. TWST: 60%
Market capitalization -- CHEK: $18.19M vs. TWST: $1.98B
CHEK [@Medical Specialties] is valued at $18.19M. TWST’s [@Medical Specialties] market capitalization is $1.98B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CHEK’s FA Score shows that 1 FA rating(s) are green whileTWST’s FA Score has 0 green FA rating(s).

  • CHEK’s FA Score: 1 green, 4 red.
  • TWST’s FA Score: 0 green, 5 red.
According to our system of comparison, TWST is a better buy in the long-term than CHEK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CHEK’s TA Score shows that 5 TA indicator(s) are bullish while TWST’s TA Score has 4 bullish TA indicator(s).

  • CHEK’s TA Score: 5 bullish, 2 bearish.
  • TWST’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CHEK is a better buy in the short-term than TWST.

Price Growth

CHEK (@Medical Specialties) experienced а -0.59% price change this week, while TWST (@Medical Specialties) price change was +9.16% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.80%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -2.09%.

Reported Earning Dates

CHEK is expected to report earnings on May 09, 2025.

TWST is expected to report earnings on Aug 01, 2025.

Industries' Descriptions

@Medical Specialties (+4.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TWST($1.98B) has a higher market cap than CHEK($18.2M). TWST YTD gains are higher at: -13.557 vs. CHEK (-34.337). CHEK has higher annual earnings (EBITDA): -18.8M vs. TWST (-172.41M). TWST has more cash in the bank: 311M vs. CHEK (32.1M). CHEK has less debt than TWST: CHEK (83K) vs TWST (91.9M). TWST has higher revenues than CHEK: TWST (262M) vs CHEK (0).
CHEKTWSTCHEK / TWST
Capitalization18.2M1.98B1%
EBITDA-18.8M-172.41M11%
Gain YTD-34.337-13.557253%
P/E RatioN/AN/A-
Revenue0262M-
Total Cash32.1M311M10%
Total Debt83K91.9M0%
FUNDAMENTALS RATINGS
CHEK vs TWST: Fundamental Ratings
CHEK
TWST
OUTLOOK RATING
1..100
355
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
43
Fair valued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9494
PRICE GROWTH RATING
1..100
9463
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHEK's Valuation (22) in the Medical Specialties industry is in the same range as TWST (43) in the Biotechnology industry. This means that CHEK’s stock grew similarly to TWST’s over the last 12 months.

TWST's Profit vs Risk Rating (93) in the Biotechnology industry is in the same range as CHEK (100) in the Medical Specialties industry. This means that TWST’s stock grew similarly to CHEK’s over the last 12 months.

TWST's SMR Rating (94) in the Biotechnology industry is in the same range as CHEK (94) in the Medical Specialties industry. This means that TWST’s stock grew similarly to CHEK’s over the last 12 months.

TWST's Price Growth Rating (63) in the Biotechnology industry is in the same range as CHEK (94) in the Medical Specialties industry. This means that TWST’s stock grew similarly to CHEK’s over the last 12 months.

TWST's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CHEK (100) in the Medical Specialties industry. This means that TWST’s stock grew similarly to CHEK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CHEKTWST
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
CHEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TWST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLUSX15.460.34
+2.25%
Lazard US Equity Focus R6
GCTAX41.54N/A
N/A
Goldman Sachs US Tax-Managed Eq A
SMDVX16.62N/A
N/A
Hartford Schroders US MidCap Opps A
FSMDX31.36N/A
N/A
Fidelity Mid Cap Index
PICOX43.06N/A
N/A
Putnam International Capital Opp R6

CHEK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHEK has been loosely correlated with IINN. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CHEK jumps, then IINN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHEK
1D Price
Change %
CHEK100%
-0.46%
IINN - CHEK
36%
Loosely correlated
+4.52%
NVNO - CHEK
27%
Poorly correlated
+3.45%
TWST - CHEK
26%
Poorly correlated
+1.84%
RSLS - CHEK
26%
Poorly correlated
-2.00%
ICAD - CHEK
26%
Poorly correlated
+1.92%
More